Pharmacokinetic and fetal cardiovascular effects of enalaprilat administration to maternal rhesus macaques

This publication has 16 references indexed in Scilit:

• Teratogen update: Angiotensin‐converting enzyme inhibitors
  Teratology, 1994
• Risks of angiotensin-converting enzyme inhibition during pregnancy: Experimental and clinical evidence, potential mechanisms, and recommendations for use
  The American Journal of Medicine, 1994
• The effects of a converting enzyme inhibitor (Captopril) and angiotensin II on fetal renal function
  British Journal of Pharmacology, 1993
• Pharmacokinetic Optimisation of Angiotensin Converting Enzyme (ACE) Inhibitor Therapy
  Clinical Pharmacokinetics, 1992
• Circadian myometrial and endocrine rhythms in the pregnant rhesus macaque: Effects of constant light and timed melatonin infusion
  American Journal of Obstetrics and Gynecology, 1991
• Circadian Uterine Activity in the Pregnant Rhesus Macaque: Do Prostaglandins Play a Role?1
  Biology of Reproduction, 1989
• The effect of enalapril (MK421), an angiotensin converting enzyme inhibitor, on the conscious pregnant ewe and her foetus
  British Journal of Pharmacology, 1986
• Enalapril
  Drugs, 1986
• Enalapril maleate and a lysine analogue (MK‐521): disposition in man.
  British Journal of Clinical Pharmacology, 1982